ENXTPA:ORAP

Stock Analysis Report

Executive Summary

Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide.


Snowflake Analysis

Undervalued with questionable track record.

Share Price & News

How has Orapi's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ORAP's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-9.2%

ORAP

0.1%

FR Chemicals

-0.5%

FR Market


1 Year Return

12.6%

ORAP

34.9%

FR Chemicals

15.2%

FR Market

Return vs Industry: ORAP underperformed the French Chemicals industry which returned 34.9% over the past year.

Return vs Market: ORAP underperformed the French Market which returned 15.2% over the past year.


Shareholder returns

ORAPIndustryMarket
7 Day-9.2%0.1%-0.5%
30 Day-9.5%7.4%1.3%
90 Day60.6%11.3%3.5%
1 Year12.6%12.6%38.1%34.9%19.2%15.2%
3 Year-33.7%-33.7%64.4%53.5%43.8%30.2%
5 Year-50.2%-51.4%64.9%43.4%52.3%30.8%

Price Volatility Vs. Market

How volatile is Orapi's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Orapi undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ORAP (€5.7) is trading below our estimate of fair value (€26.19)

Significantly Below Fair Value: ORAP is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ORAP is good value based on its PE Ratio (8.3x) compared to the Chemicals industry average (20.9x).

PE vs Market: ORAP is good value based on its PE Ratio (8.3x) compared to the French market (18.6x).


Price to Earnings Growth Ratio

PEG Ratio: ORAP's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: ORAP is good value based on its PB Ratio (0.5x) compared to the FR Chemicals industry average (1.4x).


Next Steps

Future Growth

How is Orapi forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-58.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORAP's earnings are forecast to decline over the next 3 years (-58.9% per year).

Earnings vs Market: ORAP's earnings are forecast to decline over the next 3 years (-58.9% per year).

High Growth Earnings: ORAP's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ORAP's revenue is expected to decline over the next 3 years (-1% per year).

High Growth Revenue: ORAP's revenue is forecast to decline over the next 3 years (-1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORAP is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has Orapi performed over the past 5 years?

-13.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORAP has a large one-off gain of €2.4M impacting its June 30 2019 financial results.

Growing Profit Margin: ORAP became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: ORAP has become profitable over the past 5 years, growing earnings by -13.3% per year.

Accelerating Growth: ORAP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: ORAP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.4%).


Return on Equity

High ROE: ORAP's Return on Equity (6.6%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Orapi's financial position?


Financial Position Analysis

Short Term Liabilities: ORAP's short term assets (€105.4M) exceed its short term liabilities (€95.9M).

Long Term Liabilities: ORAP's short term assets (€105.4M) exceed its long term liabilities (€67.4M).


Debt to Equity History and Analysis

Debt Level: ORAP's debt to equity ratio (155.6%) is considered high.

Reducing Debt: ORAP's debt to equity ratio has increased from 129.9% to 155.6% over the past 5 years.


Balance Sheet

Inventory Level: ORAP has a high level of physical assets or inventory.

Debt Coverage by Assets: ORAP's debt is covered by short term assets (assets are 1.4x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ORAP is profitable, therefore cash runway is not a concern.

Forecast Cash Runway: ORAP is profitable, therefore cash runway is not a concern.


Next Steps

Dividend

What is Orapi's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%1.5%markettop25%4.6%industryaverage2.0%forecastin3Years0%

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate ORAP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ORAP's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ORAP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ORAP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ORAP is not paying a notable dividend for the French market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ORAP's dividend in 3 years as they are not forecast to pay a notable one for the French market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.3yrs

Average board tenure


CEO

Guy Chifflot 0

€624,000

Compensation

Mr. Monsieur Guy Chifflot serves as the Chairman, Chief Executive Officer and President of Orapi. Mr. Chifflot serves as a Manager of ORAPI Europe and Orapi International. Mr. Chifflot serves as the Managi ...


CEO Compensation Analysis

Compensation vs Market: Guy's total compensation ($USD677.82K) is above average for companies of similar size in the French market ($USD308.22K).

Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Guy Chifflot
Chairman of the Board0yrs€624.00kno data
Fabienne Chifflot
Head of Communications & Director0yrs€49.34kno data
Henri Biscarrat
Deputy CEO & Director9.8yrs€273.61kno data
Fabrice Chifflot
Director and Managing Director of Asia & Middle East0yrs€279.95kno data
René Perrin
Independent Director17.8yrs€2.40kno data
Jean-Pierre Gaillard
Director6.8yrs€1.60kno data
Carole Dufour
Independent Director4.8yrs€2.40kno data
Laurence Balas
Independent Director0yrsno datano data
Celine Fantin
Independent Director0yrsno datano data

8.3yrs

Average Tenure

Experienced Board: ORAP's board of directors are considered experienced (8.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Orapi SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Orapi SA
  • Ticker: ORAP
  • Exchange: ENXTPA
  • Founded: 1968
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: €26.116m
  • Shares outstanding: 4.58m
  • Website: https://www.orapi.com

Number of Employees


Location

  • Orapi SA
  • PARC INDUSTRIEL DE LA PLAINE DE L'AIN
  • 225 ALLÉE DES CÈDRES
  • Saint-Vulbas
  • Rhône-Alpes
  • 1150
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ORAPENXTPA (Euronext Paris)YesOrdinary SharesFREURApr 2000
0ICILSE (London Stock Exchange)YesOrdinary SharesGBEURApr 2000
ORAPPBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURApr 2000

Biography

Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide. The company provides cleaning and disinfection products, and products for equipment and machine upkeep. It serves transportation, health care, and others industries; local government; and cleaning companies and recreation/shops. The company was founded in 1968 and is based in Saint-Vulbas, France. Orapi SA is a subsidiary of Financière MG3F. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/22 21:11
End of Day Share Price2020/02/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.